People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Convenience Network, Inc. | — | Other | Pre-Seed | $853K | $19.7M | 2014 |
| Ionogen, Inc. | — | Biotechnology | Pre-Seed | $500K | $27.6M | 2019 |
Douglas Yoakley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Yoakley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Terry Douglass | 1 | 4 |
| Steve Newman | 1 | 3 |
| David Belitz | 1 | 2 |
| William Sansom | 1 | 1 |
| John Shanahan | 1 | 1 |
| Dale Keasling | 1 | 1 |
| Rob Zimmer | 1 | 1 |
| Michael Hatcher | 1 | 1 |
| Bergein Overholt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.